drugset / Trial / NCT00595374

Efficacy and Safety of Insulin Detemir in Type 1 Diabetes

NCT00595374

Phase 3 Completed 114 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in Europe. The aim of this trial is to compare the efficacy and safety of insulin detemir and insulin NPH in adults with type 1 diabetes on blood glucose control.

Timeline

Start
2003-12-02
Primary completion
2004-10-07
Completion
2004-10-07

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin NPH Protein / enzyme biologic
Subject insulin detemir Protein / enzyme biologic
Background insulin aspart Protein / enzyme biologic